Claritev Corporation
CTEVNYSEHealthcare● Active
$25.90
+$0.06(+0.23%)
Market Cap$441537735
P/E Ratio—
52W High$74.07
52W Low$11.5
Claritev Corporation (CTEV) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · CTEV · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.97B | $0.93B | $0.96B | $1.08B | $1.12B |
| Cost of Revenue | $0.70B | $0.24B | $0.24B | $0.20B | $0.18B |
| Gross Profit | $0.27B | $0.69B | $0.73B | $0.88B | $0.94B |
| Gross Margin %(computed) | 27.61% | 74.27% | 75.51% | 81.10% | 84.32% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.22B | $0.16B | $0.14B | $0.13B | $0.15B |
| Total Operating Expenses | $0.22B | $2.08B | $0.56B | $1.24B | $0.56B |
| Operating Income | $0.05B | ($1.39B) | $0.16B | ($0.36B) | $0.39B |
| Operating Margin %(computed) | 4.67% | -149.35% | 16.85% | -33.60% | 34.55% |
| Interest Income | $0.00B | $0.00B | $0.01B | $0.00B | $0.00B |
| Interest Expense | $0.40B | $0.33B | $0.33B | $0.30B | $0.27B |
| Income Before Tax | ($0.37B) | ($1.77B) | ($0.11B) | ($0.56B) | $0.14B |
| Income Tax Expense | ($0.09B) | ($0.12B) | ($0.02B) | $0.01B | $0.03B |
| Net Income | ($0.28B) | ($1.65B) | ($0.09B) | ($0.57B) | $0.10B |
| Net Margin %(computed) | -29.45% | -176.85% | -9.54% | -53.06% | 9.13% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-17.30 | $-101.92 | $-5.69 | $-35.87 | $6.40 |
| Wtd Avg Shares | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B |
| EBITDA | $0.48B | ($1.01B) | $0.65B | $0.16B | $0.81B |
| EBITDA Margin %(computed) | 49.25% | -108.30% | 67.80% | 14.66% | 72.92% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Claritev Corporation data
About Claritev Corporation (CTEV) Income Statement
Claritev Corporation (CTEV) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, CTEV reported revenue of $0.97B, gross profit of $0.27B (gross margin 27.61%), and net income of ($0.28B) — a net profit margin of -29.45%.
Frequently asked questions
CTEV · 4 questionsClaritev Corporation (CTEV) reported revenue of $0.97B for 2025, up 3.7% year-over-year.
CTEV revenueCTEV salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08